These FAP-expressing CAFs have been proposed to accelerate proliferation, invasion, and therapeutic resistance in ovarian cancer cells (30), and have also been suggested to reprogram tumor inflammatory environments in human intrahepatic cholangiocarcinoma via FAP-STAT3-CCL2 signaling (31). Here, FAP is linked to intrahepatic cholangiocarcinoma.